IMS — Invent Medic Sweden AB Income Statement
0.000.00%
Last trade - 00:00- SEK11.85m
- SEK14.92m
- SEK7.35m
Annual income statement for Invent Medic Sweden AB, fiscal year end - December 31st, SEK millions except per share, conversion factor applied.
2020 December 31st | 2021 December 31st | 2022 December 31st | 2023 December 31st | 2024 December 31st | |
|---|---|---|---|---|---|
| Period Length: | 12 M | 12 M | 12 M | 12 M | 12 M |
| Source: | ARS | ARS | ARS | ARS | ARS |
| Standards: | SAS | SAS | SAS | SAS | SAS |
| Status: | Final | Final | Final | Final | Final |
| Revenue | |||||
| Total Revenue | 1.52 | 1.88 | 3.11 | 6.71 | 7.35 |
| Cost of Revenue | |||||
| Gross Profit | 1.08 | 1.46 | 2.45 | 5.22 | 5.7 |
| Selling / General / Administrative Expenses | |||||
| Research And Development | |||||
| Depreciation and Amortization | |||||
| Other Operating Expenses | |||||
| Total Operating Expenses | 16.9 | 20.7 | 14.9 | 14.9 | 13.6 |
| Operating Profit | -15.4 | -18.8 | -11.8 | -8.15 | -6.22 |
| Total Net Non Operating Interest Income / Expense | |||||
| Net Income Before Taxes | -15.6 | -19 | -12 | -8.53 | -7.65 |
| Provision for Income Taxes | |||||
| Net Income After Taxes | -15.6 | -19 | -12 | -8.53 | -7.65 |
| Net Income Before Extraordinary Items | |||||
| Net Income | -15.6 | -19 | -12 | -8.53 | -7.65 |
| Income Available to Common Shareholders Excluding Extraordinary Items | |||||
| Income Available to Common Shareholders Including Extraordinary Items | |||||
| Diluted Net Income | -15.6 | -19 | -12 | -8.53 | -7.65 |
| Diluted Weighted Average Shares | |||||
| Basic EPS Including Extraordinary Items | |||||
| Diluted EPS Including Extraordinary Items | |||||
| Diluted EPS Excluding Extraordinary Items | |||||
| Normalised Income Before Taxes | |||||
| Normalised Income After Taxes | |||||
| Normalised Income Available to Common Shareholders | |||||
| Diluted Normalised EPS | -0.949 | -0.681 | -0.428 | -0.202 | -0.111 |
| Dividends per Share |